THE COST OF SUICIDE AND SUICIDE ATTEMPTS IN THE UNITED-STATES

Citation
Cs. Palmer et al., THE COST OF SUICIDE AND SUICIDE ATTEMPTS IN THE UNITED-STATES, Clinical neuropharmacology, 18, 1995, pp. 25-33
Citations number
19
Categorie Soggetti
Clinical Neurology","Pharmacology & Pharmacy
Journal title
ISSN journal
03625664
Volume
18
Year of publication
1995
Supplement
3
Pages
25 - 33
Database
ISI
SICI code
0362-5664(1995)18:<25:TCOSAS>2.0.ZU;2-S
Abstract
Suicide is ranked eighth as a cause of death in the United States and is the third leading cause of death in the 15- to 24-year age group. S chizophrenia, along with depression, is an important risk factor for s uicide and attempted suicide. The incidence of suicide in 1994 has bee n estimated along with the 1994 projected costs of suicide and suicide attempts. The projected number of completed suicides for 1994 was ove r 32,000, with an estimated 109,500 hospitalizations for suicide attem pts. Completed suicides resulted in direct costs and indirect costs re lating to loss of earnings, with the total cost estimated at over $397 ,000 (U.S.) per suicide. Suicide attempts incur greater direct costs d uring hospitalization and a percentage of patients will suffer permane nt disability requiring long-term care and loss of earnings; total cos ts averaged over $33,000 (U.S.) per attempt. Major cost savings may be achieved by targeting the prevention of suicide. Further research is needed to improve our understanding of suicide.